Capital restructuring of Winncare led by Siparex, in partnership with Kartesia, SOCADIF, and BNP Paribas Développement
Winncare is a leading European designer and manufacturer of medical devices dedicated to enhancing the quality of life for dependent individuals, as well as their caregivers and healthcare professionals. Over recent years, Winncare has significantly expanded its portfolio—both organically and through strategic acquisitions. With an international footprint spanning five commercial subsidiaries (France, the UK, Spain, Denmark, and Poland) and 12 production sites, the Group has established itself as a benchmark player in Europe’s medtech sector.
The investor consortium, led by Siparex ETI and comprising Kartesia, Crédit Agricole, and BNP Paribas Développement, will partner with management to accelerate the Group’s strategy, focusing on International expansion, an active M&A pipeline to consolidate its market position, and sustained organic growth, driven by innovation in a high-growth sector.